Assessment of type I interferon response in routine practice in France in 2022.
Nombel A,Foray A,Garnier L,Lombard C,Hachulla E,Bader-Meunier B,Georgin-Lavialle S,Melki I,Walzer T,Belot A,Viel S
Source :
2023 Jun 15
Pmid / DOI:
37321666
Abstract
An European Alliance of Associations for Rheumatology task force recently recommended specific points to consider for exploring type I interferon pathway in patients, highlighting the lack of analytical assays validated for clinical routine. We report here the French experience on a type I interferon pathway assay that has been set up and used routinely since 2018 in Lyon, France.KEYWORDSAutoimmune Diseases, Cytokines, Dermatomyositis, Lupus Erythematosus, Systemic© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.